Literature DB >> 19884294

Managing diabetes in hemodialysis patients: observations and recommendations.

Kumarpal Shrishrimal1, Peter Hart, Franklin Michota.   

Abstract

Diabetes is challenging to manage in patients who have end-stage renal disease (ESRD), as both uremia and dialysis can complicate glycemic control by affecting the secretion, clearance, and peripheral tissue sensitivity of insulin. The authors summarize the available evidence and make practical recommendations.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19884294     DOI： 10.3949/ccjm.76a.09054

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  15 in total

1.  Endocrine and metabolic emergencies: hypoglycaemia.

Authors:  Elora Mukherjee; Richard Carroll; Glenn Matfin
Journal:  Ther Adv Endocrinol Metab       Date:  2011-04       Impact factor: 3.565

2.  Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finland.

Authors:  R Lithovius; V Harjutsalo; C Forsblom; P H Groop
Journal:  Diabetologia       Date:  2010-12-07       Impact factor: 10.122

3.  Co-infusion of adipose tissue derived mesenchymal stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 diabetes mellitus with end-stage renal disease.

Authors:  Shruti D Dave; Aruna V Vanikar; Hargovind L Trivedi
Journal:  BMJ Case Rep       Date:  2013-05-23

4.  Safety and efficacy of linagliptin in type 2 diabetes patients with common renal and cardiovascular risk factors.

Authors:  Baptist Gallwitz
Journal:  Ther Adv Endocrinol Metab       Date:  2013-06       Impact factor: 3.565

Review 5.  Dialysis-associated hyperglycemia: manifestations and treatment.

Authors:  Yijuan Sun; Maria-Eleni Roumelioti; Kavitha Ganta; Robert H Glew; James Gibb; Darlene Vigil; Catherine Do; Karen S Servilla; Brent Wagner; Jonathan Owen; Mark Rohrscheib; Richard I Dorin; Glen H Murata; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2020-01-18       Impact factor: 2.370

6.  Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus.

Authors:  Candis M Morello
Journal:  Int J Gen Med       Date:  2011-12-12

7.  Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions.

Authors:  Anna Bryland; Anders Wieslander; Ola Carlsson; Thomas Hellmark; Gabriela Godaly
Journal:  Diab Vasc Dis Res       Date:  2011-11-01       Impact factor: 3.291

Review 8.  Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia.

Authors:  Guido Gembillo; Ylenia Ingrasciotta; Salvatore Crisafulli; Nicoletta Luxi; Rossella Siligato; Domenico Santoro; Gianluca Trifirò
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

9.  Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Sylvia Paz B Ramirez; Keith P McCullough; Jyothi R Thumma; Robert G Nelson; Hal Morgenstern; Brenda W Gillespie; Masaaki Inaba; Stefan H Jacobson; Raymond Vanholder; Ronald L Pisoni; Fritz K Port; Bruce M Robinson
Journal:  Diabetes Care       Date:  2012-08-21       Impact factor: 19.112

10.  Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study.

Authors:  Janet B McGill; Lance Sloan; Jennifer Newman; Sanjay Patel; Christophe Sauce; Maximilian von Eynatten; Hans-Juergen Woerle
Journal:  Diabetes Care       Date:  2012-10-01       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.